To investigate the pathophysiological implications of their findings, Rozalén and colleagues interrogated the impact of TIM-3 expression by malignant cells on breast cancer progression in a tissue microarray of 257 primary samples. The gene discussed is HAVCR2; the disease is breast carcinoma.